Physician profile
Eric S Petersen
NPI 1538149042
$1,569.06
in general payments reported to CMS, 2019-2025
15 companies · $752 in 2025
The $752 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.93 · 2021: $93.96 · 2023: $208 · 2024: $453 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127 · Education: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.24 |
| Education | $285.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $428.98 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $250.13 | 2024-2025 | Austedo Xr, Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $153.00 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $152.75 | 2021-2025 | |
| Novo Nordisk INC | $149.66 | 2023-2025 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $128.01 | 2023-2024 | Veozah |
| Lilly USA, LLC | $86.92 | 2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $54.88 | 2023-2025 | Repatha |
| Exact Sciences Corporation | $42.20 | 2024-2025 | Cologuard Collection Kit |
| Allergan, INC. | $35.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.75 | 2025 | Jardiance |
| Sanofi Pasteur INC. | $18.00 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $17.82 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $14.06 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $10.04 | 2025 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Petersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.